129 related articles for article (PubMed ID: 28339533)
1. Pneumocystis pneumonia versus rituximab-induced interstitial lung disease in lymphoma patients receiving rituximab-containing chemotherapy.
Park SY; Kim MY; Choi WJ; Yoon DH; Lee SO; Choi SH; Kim YS; Suh C; Woo JH; Kim SH
Med Mycol; 2017 Jun; 55(4):349-357. PubMed ID: 28339533
[TBL] [Abstract][Full Text] [Related]
2. Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab.
Zhou T; Shen Q; Peng H; Chao T; Zhang L; Huang L; Yang K; Thapa S; Yu S; Jiang Y
Ann Hematol; 2018 Jan; 97(1):141-147. PubMed ID: 29086009
[TBL] [Abstract][Full Text] [Related]
3. Low incidence of pneumocystis pneumonia utilizing PCR-based diagnosis in patients with B-cell lymphoma receiving rituximab-containing combination chemotherapy.
Barreto JN; Ice LL; Thompson CA; Tosh PK; Osmon DR; Dierkhising RA; Plevak MF; Limper AH
Am J Hematol; 2016 Nov; 91(11):1113-1117. PubMed ID: 27472910
[TBL] [Abstract][Full Text] [Related]
4. Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients.
Bollée G; Sarfati C; Thiéry G; Bergeron A; de Miranda S; Menotti J; de Castro N; Tazi A; Schlemmer B; Azoulay E
Chest; 2007 Oct; 132(4):1305-10. PubMed ID: 17934116
[TBL] [Abstract][Full Text] [Related]
5. Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma.
Huang YC; Liu CJ; Liu CY; Pai JT; Hong YC; Teng HW; Hsiao LT; Chao TC; Gau JP; Liu JH; Hsu HC; Chiou TJ; Chen PM; Yu YB; Tzeng CH
Ann Hematol; 2011 Oct; 90(10):1145-51. PubMed ID: 21647583
[TBL] [Abstract][Full Text] [Related]
6. Interstitial pneumonia after autologous hematopoietic stem cell transplantation in B-cell non-hodgkin lymphoma.
Kato H; Yamamoto K; Taji H; Oki Y; Chihara D; Seto M; Kagami Y; Morishima Y
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):483-9. PubMed ID: 21978956
[TBL] [Abstract][Full Text] [Related]
7. Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of Pneumocystis pneumonia in Japan revealed by a multicenter study.
Kameda H; Tokuda H; Sakai F; Johkoh T; Mori S; Yoshida Y; Takayanagi N; Taki H; Hasegawa Y; Hatta K; Yamanaka H; Dohi M; Hashimoto S; Yamada H; Kawai S; Takeuchi T; Tateda K; Goto H
Intern Med; 2011; 50(4):305-13. PubMed ID: 21325762
[TBL] [Abstract][Full Text] [Related]
8. Pneumocystis jiroveci pneumonia in patients with non-Hodgkin's lymphoma receiving chemotherapy containing rituximab.
Chang H; Yeh HC; Su YC; Lee MH
J Chin Med Assoc; 2008 Nov; 71(11):579-82. PubMed ID: 19015057
[TBL] [Abstract][Full Text] [Related]
9. Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma.
Liu X; Hong XN; Gu YJ; Wang BY; Luo ZG; Cao J
Leuk Lymphoma; 2008 Sep; 49(9):1778-83. PubMed ID: 18798110
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of pulmonary complications in non-Hodgkin's lymphoma patients treated with rituximab-containing chemotherapy and impact on survival.
Keefer K; Bender R; Liao J; Sivik J; Van de Louw A
Ann Hematol; 2018 Dec; 97(12):2373-2380. PubMed ID: 30030570
[TBL] [Abstract][Full Text] [Related]
11. Pneumocystis pneumonia in patients treated with rituximab.
Martin-Garrido I; Carmona EM; Specks U; Limper AH
Chest; 2013 Jul; 144(1):258-265. PubMed ID: 23258406
[TBL] [Abstract][Full Text] [Related]
12. Pneumocystis jirovecii pneumonia in patients treated with rituximab for systemic diseases: Report of 11 cases and review of the literature.
Alexandre K; Ingen-Housz-Oro S; Versini M; Sailler L; Benhamou Y
Eur J Intern Med; 2018 Apr; 50():e23-e24. PubMed ID: 29198498
[No Abstract] [Full Text] [Related]
13. Pneumocystis jiroveci pneumonia in patients with systemic lupus erythematosus after rituximab therapy.
Tsai MJ; Chou CW; Lin FC; Chang SC
Lupus; 2012 Jul; 21(8):914-8. PubMed ID: 22287506
[TBL] [Abstract][Full Text] [Related]
14. [Pneumocystis jiroveci pneumonia as a complication of glucocorticoid therapy for interstitial pneumonia].
Enomoto T; Azuma A; Matsumoto A; Nei T; Hiramatsu K; Abe S; Usuki J; Kudoh S
Nihon Kokyuki Gakkai Zasshi; 2005 Dec; 43(12):725-30. PubMed ID: 16457333
[TBL] [Abstract][Full Text] [Related]
15. The usefulness of a diagnostic method combining high-resolution CT findings and serum markers for cytomegalovirus pneumonia and pneumocystis pneumonia in non-AIDS patients.
Kunihiro Y; Tanaka N; Matsumoto T; Yamamoto N; Matsunaga N
Acta Radiol; 2015 Jul; 56(7):806-13. PubMed ID: 25031277
[TBL] [Abstract][Full Text] [Related]
16. Loop-mediated isothermal amplification method for diagnosing Pneumocystis pneumonia in HIV-uninfected immunocompromised patients with pulmonary infiltrates.
Nakashima K; Aoshima M; Ohkuni Y; Hoshino E; Hashimoto K; Otsuka Y
J Infect Chemother; 2014 Dec; 20(12):757-61. PubMed ID: 25187511
[TBL] [Abstract][Full Text] [Related]
17. A case of pneumocystis pneumonia associated with everolimus therapy for renal cell carcinoma.
Saito Y; Nagayama M; Miura Y; Ogushi S; Suzuki Y; Noro R; Minegishi Y; Kimura G; Kondo Y; Gemma A
Jpn J Clin Oncol; 2013 May; 43(5):559-62. PubMed ID: 23423809
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of pathologic manifestations of Pneumocystis carinii pneumonia in patients with neoplastic diseases.
Luna MA; Cleary KR
Semin Diagn Pathol; 1989 Aug; 6(3):262-72. PubMed ID: 2799114
[TBL] [Abstract][Full Text] [Related]
19. Rituximab-induced interstitial lung disease in a patient with immune thrombocytopenia purpura.
Child N; O'Carroll M; Berkahn L
Intern Med J; 2012 Mar; 42(3):e12-4. PubMed ID: 22432995
[TBL] [Abstract][Full Text] [Related]
20. Granulomatous Pneumocystis jiroveci pneumonia in a patient with diffuse large B-cell lymphoma: case report and review of the literature.
Chang H; Shih LY; Wang CW; Chuang WY; Chen CC
Acta Haematol; 2010; 123(1):30-3. PubMed ID: 19940467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
